26,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 1-2 Wochen
  • Broschiertes Buch

This book contains the results and additional details about a Cost-Effectiveness Analysis of IEV versus ESHAP for Treatment of the Patients with Relapsed/Refractory Hodgkin and Non-Hodgkin's Lymphoma in Iran. This book was provided by Mr. Mostafa Habibian, in partial fulfilment of the requirements for MSc in Health Economic. The present book was adopted from the proposal number 7044 approved by Vice Chancellor for Research Affairs of Shiraz University of Medical Sciences.

Produktbeschreibung
This book contains the results and additional details about a Cost-Effectiveness Analysis of IEV versus ESHAP for Treatment of the Patients with Relapsed/Refractory Hodgkin and Non-Hodgkin's Lymphoma in Iran. This book was provided by Mr. Mostafa Habibian, in partial fulfilment of the requirements for MSc in Health Economic. The present book was adopted from the proposal number 7044 approved by Vice Chancellor for Research Affairs of Shiraz University of Medical Sciences.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
Mostafa Habibian, MSc in Health economics, Shiraz University of Medical Sciences, 2012-2014 and BSc in Health care services management, 2007-2011. Consultant in Chief of cost monitoring in medical and Research fellow in health economics at Iran University of Medical Sciences